Articles

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

Bolar and experimental use exemptions in the EU: how the landscape has changed for generic and biotech drug makers

17.12.2014 BE law

Team

Related news